“Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis by Bodyweight: Pooled Results from Phase 3 Trials”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s73. https://doi.org/10.25251/skin.6.supp.73.